QuickView for ENOSF1 (gene)

1. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
2. L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
3. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
4. L1000 CMAP - Adipose MSC ASC52telo cells with shRNA-mediated gene knockdown
5. L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations

1. Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities…
2. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.
3. Polymorphisms in TYMS for Prediction of Capecitabine-Induced Hand-Foot Syndrome in Chinese Patients …
4. Identification of peptide regions of SERPINA1 and ENOSF1 and their protein expression as potential s…
5. ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results…

There were no clinical trials for ENOSF1